Title : Etoposide, ifosfamide, and methotrexate combination chemotherapy for aggressive non-Hodgkin's lymphomas after failure of the LNH 84 regimen.

Pub. Date : 1992 Feb

PMID : 1384135






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 We assessed the efficacy and tolerability of VIM (etoposide/ifosfamide/methotrexate) combination therapy in 24 patients who were failing the treatment protocol of the Lymphomes Non Hodgkiniens (LNH) 84 study. Etoposide vimentin Homo sapiens